Auclair-Ouellet, N.; Tremblay, A.; Kassem, O.; Caballero-Calero, S.E.; Bronner, S.; Binda, S.
Probiotics as Adjuvants to Standard Helicobacter pylori Treatment: Evidence for the Use of Lacidofil®, an Established Blend of Thoroughly Characterized Strains. Microorganisms 2025, 13, 2223.
https://doi.org/10.3390/microorganisms13102223
AMA Style
Auclair-Ouellet N, Tremblay A, Kassem O, Caballero-Calero SE, Bronner S, Binda S.
Probiotics as Adjuvants to Standard Helicobacter pylori Treatment: Evidence for the Use of Lacidofil®, an Established Blend of Thoroughly Characterized Strains. Microorganisms. 2025; 13(10):2223.
https://doi.org/10.3390/microorganisms13102223
Chicago/Turabian Style
Auclair-Ouellet, Noémie, Annie Tremblay, Ola Kassem, Sara E. Caballero-Calero, Stéphane Bronner, and Sylvie Binda.
2025. "Probiotics as Adjuvants to Standard Helicobacter pylori Treatment: Evidence for the Use of Lacidofil®, an Established Blend of Thoroughly Characterized Strains" Microorganisms 13, no. 10: 2223.
https://doi.org/10.3390/microorganisms13102223
APA Style
Auclair-Ouellet, N., Tremblay, A., Kassem, O., Caballero-Calero, S. E., Bronner, S., & Binda, S.
(2025). Probiotics as Adjuvants to Standard Helicobacter pylori Treatment: Evidence for the Use of Lacidofil®, an Established Blend of Thoroughly Characterized Strains. Microorganisms, 13(10), 2223.
https://doi.org/10.3390/microorganisms13102223